# Vidaza to Restore Hormone Thx Prostate

> **NCT00384839** · PHASE2 · COMPLETED · sponsor: **US Oncology Research** · enrollment: 36 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** azacitidine for injectable suspension

## Key facts

- **NCT ID:** NCT00384839
- **Lead sponsor:** US Oncology Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2018-10-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00384839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00384839, "Vidaza to Restore Hormone Thx Prostate". Retrieved via AI Analytics 2026-07-30 from https://api.ai-analytics.org/clinical/NCT00384839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*